摘要
用胎脾ＬＡＫ细胞加ｒＩＬ－２治疗中晚期恶性肿瘤５１例，其中ＣＲ３例，ＰＲ７例，有效率ＣＲ＋ＰＲ为１９．６％，ＣＲ＋ＰＲ＋ＭＲ为３１．４％。大多数患者临床症状改善，生活质量提高，生存期延长，治疗中未见严重副反应。
With LAK cells from fetal splenocytes plus rIL-2,51 cases of malignant patients at the coddle and advanced stages were treated. Of them,3 cases were complete response (CR),7 cases partial response (PR),and curative effects were 19. 6%(CR+PR) or 31.4% (CR+PR+MR).In most of the patients,the clinical symptoms and living quality were improved,and the periods of survival extended. No severe toxic side effects werefound.
